Browsing: Celltrion

Add preferred source South Korea’s Celltrion said in a shareholder notice that it is focusing its capabilities on global sales to achieve fourth-quarter operating profit of 600 billion won (approximately $449.6 million) or more. Having met all of its quarterly targets set at the start of the year — 300 billion won in Q1, 400…

Celltrion Group Chairman Seo Jeong-jin’s stock value rose by more than 1 trillion won in the third quarter of this year alone, with the stock assets of major domestic group heads falling by more than 18 trillion won.

Celltrion (068270.KS) is joining forces with the Kobe Biomedical Innovation Cluster (KBIC), Japan’s largest biocluster, to identify promising biotech startups. The plan is to combine Japan’s strength in basic research with Celltrion’s experience in drug development and global commercialization, extending the partnership toward securing next-generation pipeline assets.